Register
Login:
Share:
Email Facebook Twitter




Summit Ther Share Price (SUMM)



Share Price Information for Summit Ther (SUMM)


Share Price: 102.50Bid: 100.00Ask: 105.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 5.00Spread as %: 5.00%Open: 102.50High: 102.50Low: 102.50Yesterday’s Close: 102.50

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
102.50

Share Price SpacerBid
100.00

Share Price SpacerAsk
105.00

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
9,203

Share Price SpacerOpen
102.50

Share Price SpacerHigh
102.50

Share Price SpacerLow
102.50

Share Price SpacerClose
102.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 61.48m £63.02m 2,000

52 Week High 172.50 52 Week High Date 17-AUG-2015
52 Week Low 82.50 52 Week Low Date 4-MAR-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
4 7,000 2,203 -3.534 -29.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

22-Jul-16
13:09:34
101.00
5,000
Sell* 
100.00
105.00
5,050
Trade Type:
Ordinary

22-Jul-16
11:21:13
104.45
1,203
Buy* 
100.00
105.00
1,257
Trade Type:
Ordinary

22-Jul-16
08:57:37
104.345
1,000
Buy* 
100.00
105.00
1,043
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
18-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
David Wurzer held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 David Wurzer
2.33USD7,5007500
17-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
Valerie Andrews held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Valerie Andrews
2.3USD10,50010500
16-Jun-15Buy
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
2.34USD4,25014442
View more Summit Ther directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Sat 21:04Free-MoneyInteresting week102.50No Opinion
Looks like I missed and interesting AGM where the shareholders seem to have sent a clear message to the board by not approving the remuneration package. So no �60k (basic salary element) increase for Glyn just yet. He still gets a huge list of options, they just need to return results which in turn will boost the share price the achieve those option targets. So as I see the boards interests are even more aligned with shareholders than if resolution 4 had been approved. I guess this is… Read More
Fri 17:11ChrisatrdgMerck faces FDA delay for C. diff102.50Strong Buy
Thu 16:33ChrisatrdgTime to invest in Biotech?102.50Strong Buy
Time to invest in Biotech?
http://www.XX.co.uk/articles/340458/time-invest-biotech
XX =iii
http://www.iii.co.uk/articles/340458/time-invest-biotech
Edit: It may create some interest in Summit
Thu 12:38doubleup888Too quiet102.50No Opinion
I was wondering if anyone knows any events coming up we can look forward to for summit. Besides hoping for a ridinazole deal to come soon
Thu 11:17gmccRE: C-Diff antibiotics !102.50No Opinion
FYI : ridinilazole was mentioned as one of the “four novel antibiotics have been evaluated in clinical trials that offer distinct advantages over existing therapies for the treatment of CDI. “

Summit previously reported “Marked reduction in recurrence with rates of 14.3% for ridinilazole compared to 34.8% for vancomycin

Numerous publications for SMT19969 (ridinilazole) can be found :

http://www.summitplc.com/publications/

Anyway note that… Read More
Tue 10:28rotivatormanRE: AGM104.00No Opinion
I must admit to some concerns about how the company is progressing (though I was not there yesterday so this is only based on voting actions and detailed feedback of those on here). The fact that the renumeration was voted down does tell me that IIs etc are concerned with the continued lack of tangible value creating progress (in particular constant timeline slippages) and have sent a clear message to the BOD that is the case. When IIs get concerned we should all be concerned. Secondly it… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Summit Ther (SUMM) >>

Please login or register to post a message on Share Chat.






Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.